← Leaderboards
Matthew Ryan Bersi
Vanderbilt University
$845,981
Attributed
$845,981
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2019–22$250K$187.5K$125K$62.5K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$845,981 · 2
By mechanism
R00$747,000 · 1
K99$98,981 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University
Same institution · by research overlap
- Hind Lal$7,028,356
- William D Merryman$11,751,914
- Michelle Bedenbaugh$627,918
- Stephen N. Davis$16,024,395
- Jennifer Urbano Blackford$7,267,977
Others in their field
Other Emerging Leaders on “Adoptive Cell Transfers”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Bronwen Shaw · Medical College Of Wisconsin$10,707,191
- Christopher M Jewell · Baltimore Va Medical Center$4,659,871
- Michael Daniel Keller · Children'S Research Institute$4,383,748
- Raiees Ahmad Andrabi · Scripps Research Institute, The$4,211,839
- Mohamed B Ezzelarab · University Of Pittsburgh At Pittsburgh$4,078,539
Research focus
Adoptive Cell TransfersAllogeneic Bone Marrow TransplantationAnimalsAntibodiesAortic Valve DisorderArthritisAtomic Force MicroscopyAwardBaseBiologicalBiomechanical ModelBlood FlowBlood VesselsBody SystemCadherin-11CalcificationCandidate IdentificationCardiacCardiac MyocytesCardiopulmonaryCardiovascular DiseasesCardiovascular InjuryCardiovascular PhysiologyAcute Myocardial Infarction
Grant awards (4)
Identification of immunotherapeutic targets in cardiovascular disease$249,000
R00 · FY2022 · HL · contact PI
Identification of immunotherapeutic targets in cardiovascular disease$249,000
R00 · FY2021 · HL · contact PI
Identification of immunotherapeutic targets in cardiovascular disease$249,000
R00 · FY2020 · HL · contact PI
Identification of immunotherapeutic targets in cardiovascular disease$98,981
K99 · FY2019 · HL · contact PI